{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:55:53Z","timestamp":1765727753509},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.amjcard.2011.11.034","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T15:17:22Z","timestamp":1325690242000},"page":"1020-1025","source":"Crossref","is-referenced-by-count":12,"title":["Cost\u2013Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable"],"prefix":"10.1016","volume":"109","author":[{"given":"Craig I.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Straznitskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Sobieraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moise W.","family":"Anglade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2011.11.034_bib1","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIR.0b013e31820f14c0","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.034_bib3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.034_bib4","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(00)90012-6","article-title":"Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation","volume":"355","author":"Thomson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2011.11.034_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","article-title":"Atrial Fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials","volume":"32","author":"Dries","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.034_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/01.STR.24.6.796","article-title":"Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project","volume":"24","author":"Dennis","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2011.11.034_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","volume":"154","author":"Laupacis","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.293.6.699","article-title":"Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation","volume":"293","author":"O'Brien","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2011.11.034_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCOUTCOMES.108.808592","article-title":"Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation","volume":"2","author":"Patrick","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2011.11.034_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-154-1-201101040-00289","article-title":"Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation","volume":"154","author":"Freeman","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib14","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","article-title":"Risk factors for intracerebral hemorrhage in the general population: a systematic review","volume":"34","author":"Ariesen","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2011.11.034_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib16","series-title":"2003 Nationwide Inpatient Sample","year":"2003"},{"key":"10.1016\/j.amjcard.2011.11.034_bib17","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2011.11.034_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCOUTCOMES.109.883256","article-title":"Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission","volume":"2","author":"Krumholz","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2011.11.034_bib20","series-title":"Red Book","year":"2009"},{"key":"10.1016\/j.amjcard.2011.11.034_bib21","series-title":"Healthcare Cost and Utilization Project","year":"2009"},{"key":"10.1016\/j.amjcard.2011.11.034_bib22","first-page":"861","article-title":"Utilization of acute care services in the year before and after first stroke: a population-based study","volume":"46","author":"Leibson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2011.11.034_bib23","first-page":"854","article-title":"Inpatient costs of specific cerebrovascular events at five academic medical centers","volume":"46","author":"Holloway","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2011.11.034_bib24","series-title":"Secondary and Tertiary Prevention of Stroke: Patient Outcomes Research Team (PORT) Final Report\u2014Phase 1","author":"Matchar","year":"2000"},{"key":"10.1016\/j.amjcard.2011.11.034_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ahj.2008.05.032","article-title":"Longterm economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial","volume":"156","author":"Mark","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2011.11.034_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1067\/mhj.2001.114805","article-title":"Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels","volume":"141","author":"Tsevat","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2011.11.034_bib27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What is the price of life and why doesn't it increase at the rate of inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2011.11.034_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1592\/phco.31.10.975","article-title":"New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome","volume":"31","author":"Davis","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjcard.2011.11.034_bib29","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/CIRCULATIONAHA.110.985655","article-title":"Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation","volume":"123","author":"Shah","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.034_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914911034503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914911034503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T23:41:41Z","timestamp":1561160501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914911034503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0002914911034503"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2011.11.034","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}